The clinical significance of elevated CSF and plasma histamine in cerebral aneurysm surgery utilizing cardiopulmonary bypass with total circulatory arrest.
Recently there has been a renewed interest in the neurosurgical treatment of large cerebral aneurysms and AV malformations utilising cardiopulmonary bypass (CPB) and total circulatory arrest (TCA). However, the differing tolerance limits of coagulation and bleeding, pH control and fluid constraint are difficult to reconcile. Although clinical assessment, electro encephalogram (EEG) and intracranial pressure-monitoring assist in identification of cerebral damage, CPB and TCA inflict their own penalties with resultant uncertainty in post-operative neurological evaluation, and producing difficulties in interpretation and management. Additionally, an unanswered question is, to what extent the known cardiac and cerebral effects of circulating histamine might influence the post-circulatory arrest recovery in these patients, and whether this would further compromise the neurological result. We report our experience of 9 such cases who underwent this procedure, and were able to achieve a satisfactory neurological result in 7 patients with differing lesions. During the operation both CSF (from the open cranium) and blood (from the right internal jugular vein) were sampled at intervals for subsequent plasma histamine estimation. Despite markedly elevated histamine levels during CPB and TCA, this was not associated with an unfavourable neurological outcome. These early findings have given us encouragement to the useful role of CPB and TCA in these complex neurosurgical presentations, and raise interesting questions about the clinical importance of histamine-evoked cerebral ischaemia that has been demonstrated in experimental models.
Marath
A
A
Westminster Hospital, London, UK.
Richards
P
P
Man
W
W
Taylor
K M
KM
Lincoln
C
C
Soni
N
N
Rice-Edwards
J M
JM
Bartoli
A
A
Gladstone
D
D
D000328:Adult; D001145:Arrhythmias, Cardiac / Q000209:etiology; D002315:Cardiopulmonary Bypass / Q000009:adverse effects; D002493:Central Nervous System Diseases / Q000209:etiology; D006324:Heart Arrest, Induced / Q000009:adverse effects; D006632:Histamine / Q000097:blood / Q000134:cerebrospinal fluid*; D006801:Humans; D002532:Intracranial Aneurysm / Q000378:metabolism / Q000601:surgery*
D006632:Histamine